Lexapro and Food allergy - a phase IV clinical study of FDA data

Summary:

Food allergy is reported as a side effect among people who take Lexapro (escitalopram oxalate), especially for people who are female, 60+ old, also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Food allergy when taking Lexapro. It is created by eHealthMe based on reports of 82,231 people who have side effects when taking Lexapro from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Food allergy?

Food allergy is found to be associated with 618 drugs and 803 conditions by eHealthMe. Check the latest studies of Food allergy.

On Jul, 17, 2026

82,231 people reported to have side effects when taking Lexapro.
Among them, 40 people (0.05%) have Food allergy.

Among these 40 people:

What is the gender of people who have Food allergy when taking Lexapro? *

female: 77.5 %
male: 22.5 %

What is the age of people who have Food allergy when taking Lexapro? *

What are other drugs people take besides Lexapro? *

Xyrem: 8 people, 20.00%
Neurontin: 7 people, 17.50%
Omeprazole: 7 people, 17.50%
Prednisone: 6 people, 15.00%
Cromolyn Sodium: 5 people, 12.50%
Klonopin: 5 people, 12.50%
Hydrocortisone: 5 people, 12.50%
Fluticasone Propionate: 5 people, 12.50%
Seroquel: 5 people, 12.50%
Sumatriptan Succinate: 5 people, 12.50%

What are other side effects people have besides Food allergy? *

Fatigue (feeling of tiredness): 12 people, 30.00%
Drug Hypersensitivity: 11 people, 27.50%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 9 people, 22.50%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 20.00%
Weight Decreased: 8 people, 20.00%
Diarrhea: 8 people, 20.00%
Pain: 7 people, 17.50%
Nausea (feeling of having an urge to vomit): 7 people, 17.50%
Migraine (headache): 7 people, 17.50%
Headache (pain in head): 7 people, 17.50%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 17.50%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 10.00%
Drowsiness: 4 people, 10.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 7.50%
High Blood Pressure: 2 people, 5.00%
Type 2 Diabetes: 2 people, 5.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 5.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.00%
Androgenetic Alopecia (common form of hair loss): 1 person, 2.50%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and have Food allergy?

- Check whether Food allergy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lexapro:

Lexapro (91,464 reports)

Food allergy treatments and more:

Food allergy (11,416 reports)

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Food allergy:

Food allergy (618 drugs)

Browse all the conditions that are associated with Food allergy:

Food allergy (803 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Lexapro) and Lexapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.